BNP Paribas Asset Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.31M Sell
77,305
-64
-0.1% -$3.64K 0.01% 879
2026
Q1
$4.97M Buy
77,369
+18,911
+32% +$1.72M 0.01% 858
2025
Q4
$7.6M Buy
58,458
+58,271
+31,161% +$8M 0.01% 742
2025
Q3
$20K Hold
187
– – ﹤0.01% 1389
2025
Q2
$17K Buy
+187
New +$14.7K ﹤0.01% 1584

Other funds holding WGS

BNP Paribas Asset Management's WGS Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its GeneDx Holdings (WGS) stake by 0.08% in Q2 2026, selling an estimated $3.64K and leaving 77,305 shares worth $5.31M. The position accounts for 0.01% of the portfolio, ranked #879.

BNP Paribas Asset Management first reported a position in WGS in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.6M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • BNP Paribas Asset Management held 77,305 shares of GeneDx Holdings worth $5.31M as of Q2 2026.
  • BNP Paribas Asset Management sold 64 GeneDx Holdings shares in Q2 2026, an estimated $3.64K.
  • GeneDx Holdings made up 0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #879 holding.
  • BNP Paribas Asset Management first reported a position in GeneDx Holdings in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's GeneDx Holdings position peaked at $7.6M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.